Patent US4837212A successfully refreshed from Google Patents.
US4837212A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of hemolytic anemia with danazol
Assignee: University of Miami
•
Filing: 1986-12-01
•
Granted: 1989-06-06
•
Expires: 2006-12-01
Abstract
Abstract Danazol, a known androgen, is used to (1) correct immune abnormalities associated with hemotologic disorders or (2) treating immune disorders associated with depressed T helper cells, in the invention disclosed.
Inventors
- 👤 William J. Harrington
- 👤 Yeon S. Ahn
- 👤 Ravindra Mylvaganam
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 23:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/58
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
23 words
A method of treating autoimmune hemolytic anemia which comprises administering to a person in need of such treatment, an effective amount of danazol.
Claim 2
Independent Claim
23 words
A method of treating autoimmune hemolytic anemia which comprises administering to a person in need of such treatment, an effective amount of danazol.
Claim 3
Dependent Claim
18 words
The method of claim 1 in which from 100 to 1,000 mg. of danazol are administered per day.
References Cited (Backward Citations)
US3135743A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-05 | 1992-12-05 | 1993-06-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-05 | 1996-12-05 | 1997-06-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-05 | 2000-12-05 | 2001-06-06 | $7700.00 | Window Closed / Lapsed |